Amega Biotech- Francisco Molinari, CEO – Argentina
Francisco Molinari, CEO of Argentina’s most sophisticated biotech group discusses Argentina’s competitiveness…
AMEGA Biotech
Last updated: 12.01.2015
AMEGA Biotech is a biotechnology organization with a new vision on the production and commercialization of human biopharmaceuticals aimed at achieving the highest quality standards.
With a focus on competitiveness and time-to-market, structure of AMEGA Biotech allows control of all the manufacturing processes, from the Active Pharmaceutical Ingredient (API) to the Finished Dosage Form.
With a strong development platform and four production sites, AMEGA Biotech develops and produces biosimilars. Exporting recombinant proteins worldwide and focused on central markets registrations, AMEGA Biotech is the leading regional producer. At present, AMEGA Biotech products are available in markets such as the US, Brazil, Chile, Colombia, Uruguay, Mexico, Paraguay and Venezuela, Middle East (Egypt, Iran, Pakistan, Russia and Ukraine) and Southwest Asia (Singapore and Vietnam).
Parque Austral – Insignia Building M1
Avenida Sargento Cayetano Beliera 3025
B1629WWA | Pilar | Bs.As. | Argentina |
Phone: +54 230 438.5600
info@amegabiotech.com
Interviews
Interview with Francisco Molinari, CEO, Amega Biotech
What was the vision behind the creation of the umbrella organisation Amega Biotech in 2005? What led you to…
Related
LatAm / SIOP President on Urgent Need for Investment in Paediatric Oncology Research
Dr Guillermo Chantada, incoming president-elect of the International Society of Paediatric Oncology (SIOP)…
Interview: Fabrice Chouraqui – President Latin America & Canada,…
PharmaBoardroom spoke to Fabrice Chouraqui, President of Novartis Latin America and Canada at the Financial Times…
Martin Sabignoso – National Coordinator, Plan Nacer/Sumar – Argentina
The national coordinator of Plan Nacer and Plan Sumar – two social security programs to improve access to…
Pablo Hammerschmidt – Senior Director of Clinical Trial Management, Icon…
A senior director for Icon plc discusses Argentina’s strengths and weaknesses as a venue for clinical trials, the…
Wanda Dobrzanski – President, CAOIC & VP Latin America and General…
Dr. Wanda Dobrzanski discusses Argentina’s potential and attractiveness as a clinical research environment and…
Luis Rodriguez – General Director, Gador, Argentina
Gador’s first general director from outside of the family discusses his mission, Gador’s key to success, and…
Antonio Bouzada – President and Founder, Eriochem, Argentina
The founder of Eriochem discusses his firm’s ambitious technology based on a competitive IP strategy and its…
Patricio Silva Young – General Manager, IMS Health Argentina – South…
The general manager of IMS Health Argentina – South Cone weighs in on why his organization plays a crucial role…
Dr. Javier Valverde – Health Commission President, Camara Argentinos-China
Dr. Valverde, a respected authority on pharmacovigilance from the University of Mamonides, discusses the emerging…
Francisco Cervo – General Manager, Elea Argentina
Laboratorios Elea’s General Manager tells the story of the laboratories outstanding growth over the previous five…
Juan Carlos Monge, President and Founder – Bomi Argentina
The founder of Bomi Group’s affiliate in Argentina discusses the accomplishments of his firm thus far, and the…
Rosario Cestau, Country Manager, Aegerion Argentina
Aegerion’s representative in Argentina discusses her efforts to raise awareness of Homozygous Familial…
